AIMS: To examine the structure of illicit opioid abuse and dependence within an opioid dependent sample and its relationship to other clinical variables. DESIGN, SETTING AND PARTICIPANTS: A cross-sectional study of 1511 opioid dependent individuals recruited through opioid pharmacotherapy clinics in the Sydney area, Australia. MEASUREMENTS: A face-to-face structured interview covering substance use and dependence, psychiatric history, child maltreatment, family background, adult violence and criminal history. Dimensional, latent class and factor mixture models were fit to the opioid abuse and dependence data. Classes were then compared on a range of demographic and clinical covariates. FINDINGS: A two-class, one-factor model provided the best fit of all the models tested. The two classes differed with respect to endorsement probabilities on a range of abuse and dependence criteria, and also with respect to the odds of other drug dependence diagnoses, antisocial personality disorder and non-fatal opioid overdose. Within-class severity was associated with similar variables: other drug dependence, borderline personality disorder and opioid overdose. CONCLUSION: In an in-treatment, opioid-dependent sample, there appears to be two classes of individuals exhibiting distinct patterns of abuse and dependence criteria endorsement and to differ on externalizing but not internalizing disorders. This study provides preliminary evidence that the proposed DSM-V opioid use disorder distinction between moderate and severely dependent people is valid. Class one participants were not only more severely dependent, but had greater odds for opioid overdoses, other drug dependence and antisocial personality disorder.
AIMS: To examine the structure of illicit opioid abuse and dependence within an opioid dependent sample and its relationship to other clinical variables. DESIGN, SETTING AND PARTICIPANTS: A cross-sectional study of 1511 opioid dependent individuals recruited through opioid pharmacotherapy clinics in the Sydney area, Australia. MEASUREMENTS: A face-to-face structured interview covering substance use and dependence, psychiatric history, child maltreatment, family background, adult violence and criminal history. Dimensional, latent class and factor mixture models were fit to the opioid abuse and dependence data. Classes were then compared on a range of demographic and clinical covariates. FINDINGS: A two-class, one-factor model provided the best fit of all the models tested. The two classes differed with respect to endorsement probabilities on a range of abuse and dependence criteria, and also with respect to the odds of other drug dependence diagnoses, antisocial personality disorder and non-fatal opioid overdose. Within-class severity was associated with similar variables: other drug dependence, borderline personality disorder and opioid overdose. CONCLUSION: In an in-treatment, opioid-dependent sample, there appears to be two classes of individuals exhibiting distinct patterns of abuse and dependence criteria endorsement and to differ on externalizing but not internalizing disorders. This study provides preliminary evidence that the proposed DSM-V opioid use disorder distinction between moderate and severely dependent people is valid. Class one participants were not only more severely dependent, but had greater odds for opioid overdoses, other drug dependence and antisocial personality disorder.
Authors: James W Langenbucher; Erich Labouvie; Christopher S Martin; Pilar M Sanjuan; Lawrence Bavly; Levent Kirisci; Tammy Chung Journal: J Abnorm Psychol Date: 2004-02
Authors: A W Loranger; N Sartorius; A Andreoli; P Berger; P Buchheim; S M Channabasavanna; B Coid; A Dahl; R F Diekstra; B Ferguson Journal: Arch Gen Psychiatry Date: 1994-03
Authors: Robert F Krueger; Penny E Nichol; Brian M Hicks; Kristian E Markon; Christopher J Patrick; William G Iacono; Matt McGue Journal: Psychol Assess Date: 2004-06
Authors: Caleb J Banta-Green; Joseph O Merrill; Suzanne R Doyle; Denise M Boudreau; Donald A Calsyn Journal: Drug Alcohol Depend Date: 2009-05-26 Impact factor: 4.492
Authors: Leah Wetherill; Manav Kapoor; Arpana Agrawal; Kathleen Bucholz; Daniel Koller; Sarah E Bertelsen; Nhung Le; Jen-Chyong Wang; Laura Almasy; Victor Hesselbrock; John Kramer; John I Nurnberger; Marc Schuckit; Jay A Tischfield; Xiaoling Xuei; Bernice Porjesz; Howard J Edenberg; Alison M Goate; Tatiana Foroud Journal: Alcohol Clin Exp Res Date: 2013-09-09 Impact factor: 3.455
Authors: Silvia S Martins; Luis E Segura; Julian Santaella-Tenorio; Alexander Perlmutter; Miriam C Fenton; Magdalena Cerdá; Katherine M Keyes; Lilian A Ghandour; Carla L Storr; Deborah S Hasin Journal: Addict Behav Date: 2016-08-30 Impact factor: 3.913
Authors: Thomas F Northrup; Angela L Stotts; Charles Green; Jennifer S Potter; Elise N Marino; Robrina Walker; Roger D Weiss; Madhukar Trivedi Journal: Addict Behav Date: 2014-09-28 Impact factor: 3.913
Authors: Elliot C Nelson; Michael T Lynskey; Andrew C Heath; Naomi Wray; Arpana Agrawal; Fiona L Shand; Anjali K Henders; Leanne Wallace; Alexandre A Todorov; Andrew J Schrage; Nancy L Saccone; Pamela A F Madden; Louisa Degenhardt; Nicholas G Martin; Grant W Montgomery Journal: JAMA Psychiatry Date: 2013-03 Impact factor: 21.596
Authors: Karen P Hayhurst; Matthias Pierce; Matthew Hickman; Toby Seddon; Graham Dunn; John Keane; Tim Millar Journal: Int J Drug Policy Date: 2016-10-19
Authors: Jill A Rabinowitz; Beth A Reboussin; Johannes Thrul; Deborah A G Drabick; Geoffrey Kahn; Kerry M Green; Nicholas S Ialongo; Andrew S Huhn; Brion S Maher Journal: J Clin Child Adolesc Psychol Date: 2021-03-10